Skip to main content
TipRanks
Go Ultimate75% OFF

Repligen (RGN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

RGN Analyst Ratings

Strong Buy
8Ratings
7Buy1Hold0Sell
Based on 8 analysts giving stock ratings to Repligen in the past 3 months

RGN Stock 12 Month Forecast

CHF173.58â–²(0.00% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Repligen in the last 3 months. The average price target is CHF 173.58 with a high forecast of CHF 193.97 and a low forecast of CHF 148.58. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF193.97Average Price TargetCHF173.58Lowest Price TargetCHF148.58

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:RGN
Price TargetArticle
Stifel NicolausCHF170.86buy―Reiterated11/11/26
RBC CapitalCHF165.09buy―Reiterated11/01/26
J.P. MorganCHF165.09→CHF169.21buy―Reiterated10/29/26
Canaccord GenuityCHF148.58hold―Reiterated10/28/26
BarclaysCHF185.72buy―Reiterated10/28/26
UBSCHF193.97buy―Reiterated10/28/26
KeyBancCHF181.59buy―Reiterated10/28/26
Craig-Hallum―buy―Reiterated09/25/26
William Blair―buy―Reiterated07/28/26
TD CowenCHF165.09buy―Reiterated07/28/26
StoneXCHF152.70buy―Upgraded07/07/26
Evercore ISICHF123.81→CHF132.07buy―Reiterated07/06/26
HSBCCHF140.32→CHF123.81buy―Reiterated06/03/26
Wolfe ResearchCHF119.69buy―Initiated06/01/26
Guggenheim Analyst forecast on CH:RGNUnknown AnalystNot RankedGuggenheim―hold―Reiterated05/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Repligen

3 Months
Luke Sergott
Luke SergottBarclays
Success Rate8/10 ratings generated profit
80%
Average Return
+9.87%

Copying Luke Sergott's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +9.87% per trade.

1 Year
Luke Sergott
Luke SergottBarclays
Success Rate10/10 ratings generated profit
100%
Average Return
+21.86%

Copying Luke Sergott's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.86% per trade.

2 Years
Success Rate11/11 ratings generated profit
100%
Average Return
+30.03%

Copying Brandon Couillard's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +30.03% per trade.

RGN Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for RGN
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy40000
Buy2118171315
Hold52333
Sell00000
Strong Sell00000
total3020201618

In the current month, RGN has received 15 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. RGN average Analyst price target in the past 3 months is 173.58.

RGN Financial Forecast

CHF-1CHF-0.5CHF0CHF0.5CHF1Q1 2026Q3 2026Q4 2026
HighCHF0.44
ConsensusCHF0.43
LowCHF0.41

RGN Earnings Forecast

Next quarter’s earnings estimate for RGN is CHF 0.43 with a range of CHF 0.41 to CHF 0.44. The previous quarter’s EPS was CHF 0.43. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF158.2MCHF168.6MCHF179.1MCHF189.6MCHF200.1MQ1 2026Q3 2026Q4 2026
HighCHF200M
ConsensusCHF196M
LowCHF195M

RGN Sales Forecast

Next quarter’s sales forecast for RGN is CHF 196.26M with a range of CHF 195.26M to CHF 200.06M. The previous quarter’s sales results were CHF 170.44M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

RGN Stock Forecast FAQ

What is CH:RGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Repligen’s 12-month average price target is CHF173.58.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Repligen a Buy, Sell or Hold?
Repligen has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is Repligen’s share price target?
The average share price target for Repligen is CHF173.58. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF193.97, and the lowest forecast is CHF148.58. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Repligen?
Repligen’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Repligen?
To buy shares of CH:RGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.